Compare Stocks › ABBV vs ECL

AbbVie Inc. (ABBV) vs Ecolab Inc. (ECL): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. ECL is overvalued at $303, with an intrinsic value of $166 and a margin of safety of -82%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
ECL
Ecolab Inc.
$302.98

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
ECL
  • ★Ecolab Inc. scores 71/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Free cash flow has grown at a 21.0% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★Each dollar of retained earnings has created $2.39 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
ECL
  • ⚠FCF yield of 2.2% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠PEG ratio of 2.41 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
ABBV
ECL
Valuation
N/A
Free Cash Flow
$1.90B
N/A
FCF Yield
2.24%
50.67
Trailing P/E
41.22
18.24
Forward P/E
32.21
Quality & Moat
29.08%
ROIC
10.81%
N/A
ROE
20.77%
73.72%
Gross Margin
44.04%
0.60
PEG Ratio
2.41
Balance Sheet Safety
N/A
Net Debt / Equity
1.26
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
3.09
2.35%
Dividend Yield
0.96%
ABBV: 6Ties: 1ECL: 1
ABBVECL

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

ECL

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
ECL
$9.25
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$3.53B
Δ Market Cap
+$32.62B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ECL
52.1% Overvalued
Price is 52.1% above estimated fair value
Current Price: $302.98
Fair Value: $199.25
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

ECL

What growth rate is the market pricing in at $303?

+19.4%
Market-Implied Owner Earnings Growth
Standard FCF implies +20.6%

The market implies +19.4% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +20.6%, reflecting ongoing growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
ECL
71/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
ECL
-2.50
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ECL
Insiders 0.2%Institutions 94.2%Retail & Other 5.6%
No. of Institutional Holders2,311
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
ECL
1
Buys (3M)
6
Buys (12M)
Total value (12M): $3.93M
GREEN ERIC MARK
Director
$1.02M
@ $276.64 · 2026-09-11
CLARK BENJAMIN M.
Officer
$263,831
@ $263.83 · 2026-06-11
DOUKERIS MICHEL
Director
$2.00M
@ $258.00 · 2026-06-10
MACLENNAN DAVID W
Director
$250,650
@ $250.65 · 2026-05-13
MACLENNAN DAVID W
Director
$205,530
@ $256.91 · 2026-05-04
MACLENNAN DAVID W
Director
$193,198
@ $257.60 · 2025-12-08
MACLENNAN DAVID W
Director
$167,108
@ $278.51 · 2025-08-13
MACLENNAN DAVID W
Director
$125,872
@ $251.74 · 2025-05-07
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ECL
2
Sells (3M)
13
Sells (12M)
Total value (12M): $27.15M
BECK CHRISTOPHE
Chief Executive Officer
$5.00M
@ $280.14 · 2026-08-18
COOK GREGORY B
Officer
$1.30M
@ $285.15 · 2026-08-11
KIRKLAND SCOTT D.
Chief Financial Officer
$929,755
@ $276.96 · 2026-07-30
BROWN DARRELL R
Officer
$2.61M
@ $260.89 · 2026-06-09
VAUTRINOT SUZANNE M.
Director
$266,040
@ $264.98 · 2026-05-27
COOK GREGORY B
Officer
$1.07M
@ $304.25 · 2026-02-26
MCKIBBEN TRACY B.
Director
$390,455
@ $308.66 · 2026-02-25
BECK CHRISTOPHE
Chief Executive Officer
$6.15M
@ $307.37 · 2026-02-24
ALFANO NICHOLAS J
Officer
$2.88M
@ $303.58 · 2026-02-17
REICH VICTORIA J
Director
$301,080
@ $301.08 · 2026-02-13
BRADWAY JENNIFER J
Officer
$185,132
@ $302.01 · 2026-02-13
DE BOO ALEXANDER A
Officer
$381,452
@ $268.25 · 2025-11-24
BECK CHRISTOPHE
Chief Executive Officer
$5.68M
@ $261.41 · 2025-11-12
VAUTRINOT SUZANNE M.
Director
$383,401
@ $283.16 · 2025-08-19
BRADWAY JENNIFER J
Officer
$225,379
@ $279.28 · 2025-08-13
REICH VICTORIA J
Director
$352,300
@ $271.00 · 2025-06-12
COOK GREGORY B
Officer
$565,202
@ $253.00 · 2025-05-15
ALFANO NICHOLAS J
Officer
$2.52M
@ $253.75 · 2025-05-07
BERGER LARRY L
Chief Technology Officer
$2.90M
@ $266.95 · 2025-02-26
BRADWAY JENNIFER J
Officer
$228,866
@ $267.37 · 2025-02-25
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ECL
FearGreed
😏Greed(73/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
ECL
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (73)
View ABBV Full AnalysisView ECL Full Analysis

Frequently Asked Questions: ABBV vs ECL

Is AbbVie Inc. or Ecolab Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, ABBV trades at a -71.5% margin of safety (intrinsic value $172 vs. price $295), compared to ECL's -82.1% margin of safety (intrinsic $166 vs. $303).

Which stock has a wider economic moat, AbbVie Inc. or Ecolab Inc.?▼

ABBV scores 82/100 (Wide moat), while ECL scores 71/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. ECL scores 4.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Ecolab Inc.?▼

ABBV earns 29.1% ROIC versus ECL's 10.8%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Ecolab Inc.'s?▼

ECL's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). ECL has raised its dividend for 3 consecutive years.